Rigel Pharmaceuticals Shows Substantial Move To The Upside


Shutterstock photo

(RTTNews.com) - Shares of Rigel Pharmaceuticals ( RIGL ) have moved sharply higher during trading on Monday, with the biotech company surging up by 10.8 percent. Rigel reached its best intraday level in well over a month earlier in the session.

The jump by Rigel comes on news the FDA has accepted the company's application for the use of Tavalisse in patients with chronic or persistent immune thrombocytopenia.

For comments and feedback: contact editorial@rttnews.com




This article appears in: Stocks , Politics
Referenced Symbols: RIGL


More from RTT News

Subscribe






See headlines for RIGL

Follow on:








Research Brokers before you trade

Want to trade FX?